10mglabel (10mglabel)
Methylphenidate Capsule, Extended Release
Product Images NDC 0781-2385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methylphenidate (NDC 0781-2385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
20mglabel (20mglabel)
30mglabel (30mglabel)
40mglabel (40mglabel)
Fig1 (Fig1)
This text provides data on mean d-methylphenidate plasma levels (ng/mL) at different time intervals for two types of methylphenidate hydrochloride formulations: extended-release capsules (40mg q.d.) and tablets (20mg b.i.d.). The study was conducted on a total of 27 participants (N=17 for capsules and N=10 for tablets). The time intervals indicated suggest that the study analyzed the levels over a certain period in hours.*
Fig2 (Fig2)
This text provides information on calculating the mean final score by subtracting the mean baseline score. It also mentions the use of Methylphenidate Hydrochloride Placebo capsules. Error bars are included to represent the standard error of the mean.*
Ritalin La Structural Formula. (Ritalin La 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
